Expectedly, MAP17-dependent glycolysis and tumor growth were effectively blocked by MK-2206 (Supplementary Figure 7) or HIF1α knockdown (Supplementary Figure 8). The gene discussed is PDZK1IP1; the disease is neoplasm.